Basic nutritional investigationImmunologic and metabolic effects of high-refined carbohydrate-containing diet in food allergic mice

- We evaluate the effect of diet-induced mild obesity on the allergic response of mice.
- Mild obesity does not aggravate pathologic features of food allergy.
- Mild obesity modulates the inflammatory response during antigen challenge.
- Mild obesity causes important intestinal disorders.

ObjectiveAllergic mice show a reduction in body weight and adiposity with a higher inflammatory response in the adipose tissue similar to obese fat tissue. This study aimed to evaluate whether the low-grade inflammatory milieu of mice with diet-induced mild obesity interferes with the allergic response induced by ovalbumin (OVA).MethodsBALB/c mice were divided into four groups: 1) non-allergic (OVA−) mice fed chow diet, 2) allergic (OVA+) mice fed chow diet, 3) OVA− mice fed high-refined carbohydrate-containing (HC) diet, and 4) OVA+ mice fed HC diet. After 5 wk, allergic groups were sensitized with OVA and received a booster 14 d later. All groups received an oral OVA challenge 7 d after the booster.ResultsAllergic groups showed increased serum levels of total IgE, anti-OVA IgE, and IgG1; a high disease activity index score; aversion to OVA; and increased intestinal eosinophil infiltration. Non-allergic mild-obese mice also showed aversion to OVA and an increased number of eosinophils in the proximal jejunum. After the allergic challenge, OVA+ mice fed chow diet showed weight loss and lower adiposity in several adipose tissue depots. OVA+ mice fed HC diet showed a loss of fat mass only in the mesenteric adipose tissue. Furthermore, increased levels of TNF, IL-6, and IL-10 were observed in this tissue.ConclusionsOur data show that mild-obese allergic mice do not present severe pathologic features of food allergy similar to those exhibited by lean allergic mice. Mild obesity promoted by HC diet ingestion causes important intestinal disorders that appear to modulate the inflammatory response during the antigen challenge.